Ligand Pharmaceuticals Incorporated (LGND)
Operating return on assets (Operating ROA)
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating income (ttm) | US$ in thousands | 11,942 | -4,799 | 4,464 | 15,109 | 3,037 | 60,826 | 64,191 | 101,268 | 103,850 | 89,025 | 77,066 | 38,427 | 37,500 | 4,456 | -4,449 | -15,679 | 807,076 | 850,404 | 878,924 | 953,229 |
| Total assets | US$ in thousands | 787,216 | 769,226 | 758,105 | 811,076 | 762,668 | 1,050,600 | 1,076,290 | 1,105,180 | 1,297,590 | 1,273,660 | 1,256,280 | 1,295,120 | 1,362,280 | 1,247,450 | 1,242,940 | 1,185,920 | 1,494,920 | 1,547,480 | 1,801,840 | 1,913,990 |
| Operating ROA | 1.52% | -0.62% | 0.59% | 1.86% | 0.40% | 5.79% | 5.96% | 9.16% | 8.00% | 6.99% | 6.13% | 2.97% | 2.75% | 0.36% | -0.36% | -1.32% | 53.99% | 54.95% | 48.78% | 49.80% |
December 31, 2023 calculation
Operating ROA = Operating income (ttm) ÷ Total assets
= $11,942K ÷ $787,216K
= 1.52%
Ligand Pharmaceuticals, Inc.'s operating return on assets (Operating ROA) has shown fluctuations over the past 8 quarters. In Q1 2022, the company had a strong operating ROA of 5.87%, indicating efficient use of its assets to generate operating income. However, this ratio declined to 4.90% in Q2 2022 and further dropped to 3.95% in Q3 2022.
A significant decline was observed in Q4 2022, with the operating ROA reaching 0.40%, suggesting a potential decrease in operating efficiency or profitability during that period. The company then demonstrated improvement in Q1 2023, achieving an operating ROA of 3.27%, followed by a slight increase to 3.30% in Q2 and Q3 2023.
Overall, while there have been fluctuations in Ligand Pharmaceuticals, Inc.'s operating ROA, the company has generally maintained a positive trend with periods of improvement and some variability. It is important for stakeholders to closely monitor these ratios to assess the company's operational performance and efficiency in utilizing its assets to generate returns.
Peer comparison
Dec 31, 2023